Argenx
ARGX
#472
Rank
โ‚น5.018 T
Marketcap
โ‚น79,805
Share price
0.78%
Change (1 day)
12.83%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,529. In 2025 the company made an earnings per share (EPS) of โ‚น2,039 an increase over its 2024 EPS that were of โ‚น1,346.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415-30.61%
2025โ‚น2,03951.44%
2024โ‚น1,346-369.77%
2023-โ‚น499.13-60.46%
2022-โ‚น1,26263.33%
2021-โ‚น772.87-40.37%
2020-โ‚น1,296183.47%
2019-โ‚น457.25123.09%
2018-โ‚น204.9754.93%
2017-โ‚น132.2914.07%
2016-โ‚น115.9713.05%
2015-โ‚น102.58-36.34%
2014-โ‚น161.15209.04%
2013-โ‚น52.14-33.99%
2012-โ‚น79.00185.59%
2011-โ‚น27.66